NYSE:NAVB
Delisted

Navidea Biopharmaceuticals Stock Signals

etoro logo Buy NAVB
*Your capital is at risk
$0.0001
+0 (+0%)
At Close: Dec 30, 2025

Latest Data & Signals Issued

Below are some of the latest signals issued for Navidea Biopharmaceuticals Inc

General

Signal Type Signal Value Data
Score 0.000 61 days ( 0 %
Last Price $0.0001 0 %
Performance History
7 Days
$0.0001 $0.0001
0%
30 Days
$0.0001 $0.0001
0%
12 Mos
$0.0001 $0.0001
0%

3/18

Active Buy Signals

Specific Signals

Short Term
Net score: 15.54
Signal Type Signal Value Importance Data
High / Low N/A Very Low $0.0001 - $0.0001
Trend - 3 mos 0 % High Width: 0 %
Pred. range - 3 mos N/A - N/A Low -100.00 % - -100.00 %
Volume Direction Sell High Volume: 1 · Direction: 0
Pivot Short Buy Very Low Dec 29, 2025 - 2 days
RSI Short Pivot Signal Sell Very Low Nov 30, -0001 - N/A days
Short MA 3 mos Sell Low Nov 30, -0001 - N/A days
Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days
Short/Long MA 3 mos Sell Medium Nov 30, -0001 - N/A days

Unlock Short Term Signals

Get access to powerful short-term trading signals and real-time market insights

Subscribe Now
Long Term
Net score: 22.83
Signal Type Signal Value Importance Data
Trend - 12 mos -1.72 % Very High Width: 7,321.65 %
Pred. range - 12 mos N/A - $0.0486 High -100.00 % - 48,469.51 %
Short MA 12 mos Sell Very High Sep 16, 2025 - 74 days
Long MA 12 mos Sell Very High Jun 13, 2025 - 139 days
Short/Long MA 12 mos Sell Very High Jun 13, 2025 - 139 days
Pivot Long Buy Low Sep 30, 2025 - 64 days
RSI Long Pivot Signal Buy Low Oct 15, 2025 - 53 days
Bollinger Sell Medium Nov 30, -0001 - N/A days
MACD Neutral High No Dates Stored For This Signal
Click to get the best stock tips daily for free!
ABOUT NAVIDEA BIOPHARMACEUTICALS INC
Navidea Biopharmaceuticals
Navidea Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through two segments, Diagnostic Substances and Therapeutic Development Programs. The company develops Manocept platform to target the CD206 mannose receptor expressed on activated macrophages for a range of diagnostic modalities, including single photon emission c...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE